Endocrinology

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM) discusses what is currently known about remission when on SGLT2 inhibitors.

An internal medicine specialist explains the answer to this question in an interview with dvm360.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which received FDA clearance earlier this month

An investigation highlights the importance of cross-species genetic research and the value of animal models in rare disease studies.

The study, presented at the 2025 ACVIM Forum, found that cats aged greater than or equal to 15 years old were less likely to receive antihyperglycemic therapy.

Results were presented at the 2025 American College of Veterinary Internal Medicine (ACVIM) Forum in Louisville, Kentucky.

The new tool supports the diagnosis of Addison disease and Cushing syndrome

Kelly Cairns, DVM, MS, DACVIM (SAIM), discusses her on-demand lectures about polyarthritis and Cushing syndrome.

The FDA recently approved 2 oral SGLT2 inhibitors that are a suitable option for many newly diagnosed cats.

How should diabetic cats with these comorbidities be treated?

Veterinary professionals attending the 97th WVC Annual Conference have the opportunity to learn about the disease and treatment options for small animals.

Early diagnosis and treatment can help manage the disease and improve quality of life for affected patients.

Valerie J. Parker, DVM, DACVIM (SAIM, Nutrition), talked all about body condition score, muscle condition score, and obesity prevention during a lecture at the Fetch Long Beach conference

Vicky Ograin, MBA, RVT, VTS, explained the types of foods that appeal to pets and offered tips for making food more palatable to these animals in a Fetch dvm360 Conference lecture

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City

Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, explains how Sodium-Glucose Cotransporter 2 Inhibitors are used to manage diabetes mellitus in cats

Addison’s disease, and why it should be added to every differential list, was discussed in a session at the 2024 Fetch dvm360 Conference in Kansas City

Each article highlights different advancements in the world of veterinary diabetes treatment and management

A lecture at the Fetch dvm360 Conference in Kansas City explained how stress can cause feline interstitial cystitis and explored its diagnosis and management

Education materials and starter kits to help clients manage diabetes in their pets are accessible through the Diabetes PetCare Alliance

Alex Sigmund, DVM, DACVO, discusses health issues that topical steroids and an antiglaucoma therapy can cause, ahead of his lecture at Fetch Kansas City

Dechra Limited has purchased Akston Biosciences’ developmental therapies for cats and dogs with diabetes

How new medications on the market are improving the lives of cats and pet owners.

Therapeutic success can be maximized through dietary modifications